Renin and aldosterone measurements after captopril and supine position in differential diagnosis of adenoma and hyperplasia in primary aldosteronism.

1996 ◽  
Vol 9 (4) ◽  
pp. 91A
Author(s):  
M PEGO
2019 ◽  
Vol 21 (4) ◽  
pp. 109-113
Author(s):  
Ivan I. Sitkin ◽  
◽  
Natalia Yu. Romanova ◽  
Nadezhda M. Platonova ◽  
Natalya V. Molashenko ◽  
...  

1996 ◽  
Vol 35 (12) ◽  
pp. 919-921 ◽  
Author(s):  
Mitsuhide NARUSE ◽  
Hiroshi DEMURA ◽  
Kiyoko NARUSE ◽  
Akiyo TANABE ◽  
TOSHIROU Seki ◽  
...  

1985 ◽  
Vol 31 (6) ◽  
pp. 849-852 ◽  
Author(s):  
J E Corrie ◽  
C R Edwards ◽  
P S Budd

Abstract Increased excretion of 18-hydroxycortisol has been proposed as a specific biochemical marker for differential diagnosis of primary aldosteronism. We describe the development of a direct RIA with an 125I label that permits measurement of the steroid in less than or equal to 0.5 microL of urine or less than or equal to 25 microL of plasma. For control subjects, the mean concentrations of 18-hydroxycortisol in urine and plasma were 310 (SD 178) nmol/24 h (n = 32) and 2.27 (SD 0.80) nmol/L (n = 37), respectively; patients with Conn's adenoma or glucocorticoid-remediable aldosteronism had values for urine in the range 1084 to 6534 nmol/24 h and concentrations in plasma ranging from 6.49 to 31.20 nmol/L. Patients with idiopathic zona glomerulosa hyperplasia had values for urine and plasma ranging from 353 to 734 nmol/24 h and from 0.26 to 6.60 nmol/L, respectively. Concentrations of 18-hydroxycortisol in urine clearly discriminate patients with idiopathic hyperplasia from those with other forms of primary aldosteronism, but further work is required to assess the diagnostic accuracy of determinations in plasma.


1993 ◽  
Vol 150 (5 Part 1) ◽  
pp. 1365-1368 ◽  
Author(s):  
Philip E. Gleason ◽  
Myron H. Weinberger ◽  
J. Howard Pratt ◽  
Richard Bihrle ◽  
Jim dugan ◽  
...  

2009 ◽  
Vol 11 (3) ◽  
pp. 217-223 ◽  
Author(s):  
Paolo Mulatero ◽  
Chiara Bertello ◽  
Andrea Verhovez ◽  
Denis Rossato ◽  
Giuseppe Giraudo ◽  
...  

2010 ◽  
Vol 2010 ◽  
pp. 1-3 ◽  
Author(s):  
Saurabh Gupta ◽  
Jose Melendez ◽  
Apurv Khanna

We describe a young woman with longstanding resistant hypertension. Evaluation for renal artery stenosis and primary aldosteronism was unrevealing. In this setting of a suppressed plasma aldosterone concentration (PAC) and a suppressed plasma renin activity (PRA), a differential diagnosis of a deoxycorticosterone (DOC) producing tumor was entertained. Biochemical and imaging studies confirmed this diagnosis. Rare and novel DOC producing tumors are an important cause of resistant hypertension.


Sign in / Sign up

Export Citation Format

Share Document